These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32459039)

  • 1. Clinical and basic research investigations into the long-term effects of prenatal opioid exposure on brain development.
    Boggess T; Risher WC
    J Neurosci Res; 2022 Jan; 100(1):396-409. PubMed ID: 32459039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of the literature: How does prenatal opioid exposure impact placental health and fetal brain development?
    Humphries A; Simcox K; Howell B
    Dev Psychobiol; 2023 Apr; 65(3):e22378. PubMed ID: 36946682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal abstinence syndrome: Historical perspective, current focus, future directions.
    Jones HE; Fielder A
    Prev Med; 2015 Nov; 80():12-7. PubMed ID: 26232620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal Opioid Exposure, Neonatal Abstinence Syndrome/Neonatal Opioid Withdrawal Syndrome, and Later Child Development Research: Shortcomings and Solutions.
    Jones HE; Kaltenbach K; Benjamin T; Wachman EM; O'Grady KE
    J Addict Med; 2019; 13(2):90-92. PubMed ID: 30334926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Prediction Tool to Identify the Need for Pharmacotherapy in Infants at Risk of Neonatal Abstinence Syndrome.
    Isemann BT; Stoeckle EC; Taleghani AA; Mueller EW
    Pharmacotherapy; 2017 Jul; 37(7):840-848. PubMed ID: 28500629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends of Neonatal Abstinence Syndrome Epidemic and Maternal Risk Factors in Florida.
    Wang X; Zhu Y; Dave CV; Alrwisan AA; Voils SA; Winterstein AG
    Pharmacotherapy; 2017 Jul; 37(7):806-813. PubMed ID: 28500694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study.
    Desai RJ; Huybrechts KF; Hernandez-Diaz S; Mogun H; Patorno E; Kaltenbach K; Kerzner LS; Bateman BT
    BMJ; 2015 May; 350():h2102. PubMed ID: 25975601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between gestational age and the severity of neonatal abstinence syndrome.
    Gibson KS; Stark S; Kumar D; Bailit JL
    Addiction; 2017 Apr; 112(4):711-716. PubMed ID: 27886650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating Neonatal Abstinence Syndrome in a Rural Hospital: Lessons Learned.
    Gadomski A; Riley M; Ramiza K; Onofrey L; Zinkievich R; Krupa N; Scribani M
    Acad Pediatr; 2018; 18(4):425-429. PubMed ID: 29428413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term mortality in mothers of infants with neonatal abstinence syndrome: A population-based parallel-cohort study in England and Ontario, Canada.
    Guttmann A; Blackburn R; Amartey A; Zhou L; Wijlaars L; Saunders N; Harron K; Chiu M; Gilbert R
    PLoS Med; 2019 Nov; 16(11):e1002974. PubMed ID: 31770382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid neonatal abstinence syndrome: controversies and implications for practice.
    Wolff K; Perez-Montejano R
    Curr Drug Abuse Rev; 2014; 7(1):44-58. PubMed ID: 25323126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnoses during the First Three Years of Life for Children with Prenatal Opioid Exposure and Neonatal Abstinence Syndrome Using a Large Maternal Infant Data Hub.
    Arter S; Lambert J; Brokman A; Fall N
    J Pediatr Nurs; 2021; 61():34-39. PubMed ID: 33743318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Could prenatal food insecurity influence neonatal abstinence syndrome severity?
    Rose-Jacobs R; Trevino-Talbot M; Lloyd-Travaglini C; Cabral HJ; Vibbert M; Saia K; Wachman EM
    Addiction; 2019 Feb; 114(2):337-343. PubMed ID: 30422365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal Abstinence Syndrome in West Virginia Substate Regions, 2007-2013.
    Stabler ME; Long DL; Chertok IR; Giacobbi PR; Pilkerton C; Lander LR
    J Rural Health; 2017 Jan; 33(1):92-101. PubMed ID: 26879950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal Opioid Maintenance in the United States and Its Effect on Neonatal Abstinence Syndrome: The Case of West Virginia's Opioid Epidemic.
    Ruley M; Coustasse A
    Health Care Manag (Frederick); 2019; 38(3):258-266. PubMed ID: 31261194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reconceptualizing non-pharmacologic approaches to Neonatal Abstinence Syndrome (NAS) and Neonatal Opioid Withdrawal Syndrome (NOWS): A theoretical and evidence-based approach. Part II: The clinical application of nonpharmacologic care for NAS/NOWS.
    Velez ML; Jordan C; Jansson LM
    Neurotoxicol Teratol; 2021; 88():107032. PubMed ID: 34600100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mental Health of Mothers of Infants with Neonatal Abstinence Syndrome and Prenatal Opioid Exposure.
    Faherty LJ; Matone M; Passarella M; Lorch S
    Matern Child Health J; 2018 Jun; 22(6):841-848. PubMed ID: 29417369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thalamocortical functional connectivity in infants with prenatal opioid exposure correlates with severity of neonatal opioid withdrawal syndrome.
    Radhakrishnan R; Vishnubhotla RV; Guckien Z; Zhao Y; Sokol GM; Haas DM; Sadhasivam S
    Neuroradiology; 2022 Aug; 64(8):1649-1659. PubMed ID: 35410397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of birth defects among infants with neonatal abstinence syndrome in Illinois, 2015-2016.
    Fornoff J; Sandidge T
    Birth Defects Res; 2021 Jan; 113(2):134-143. PubMed ID: 32896979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buprenorphine: a new player in neonatal withdrawal syndrome.
    Nanda S; Brant R; Regier M; Yossuck P
    W V Med J; 2015; 111(1):16-21. PubMed ID: 25665273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.